Senti Biosciences Holdings (SNTI)

Senti Biosciences Holdings, Inc. in the Healthcare sector is trading at $0.40 with a market capitalization of $30M. Wall Street consensus targets $13.00 (3 analysts), implying a +3119.4% move over the next 12 months. The stock is currently near its 52-week low of $0.40, remaining 66.4% below its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. Risk note: RSI 11 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 50/100 suggests a balanced risk-reward profile.